MakingORG, Inc.

MakingORG, Inc.

CQCQ
MakingORG, Inc.US flagOther OTC
0.75
USD
- -
- -
26.66MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
0.02
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
-0.01
-0.01
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
-0.01
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
-0.01
-0.01
-0.03
-0.03
-0.03
- -
-0.04
Tangible Book Value per Share
- -
- -
- -
- -
- -
-0.01
-0.01
-0.01
-0.02
-0.02
- -
-0.02
Basic Weighted Avg Shares
- -
35
35
35
35
35
35
36
36
36
- -
36
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
Operating Margin (%)
- -
-905.9
- -
- -
- -
-179.24
- -
-115.71
-40.69
3.87
-242.51
-40.04
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
-1
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
160.61
- -
- -
Profit Margin (%)
- -
-905.9
- -
- -
- -
-269.04
- -
-137.83
-69.51
-0.1
-300.26
-61.64
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
-1
-1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-17.41
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
- -
-1.34
Return on Common Equity (%)
- -
-162.87
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Mar'23
Jun'23
Sep'23
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
36
36
36
Market Capitalization
27
27
- -

Working Capital

FRC

in mil. unless spec.
Mar'23
Jun'23
Sep'23
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.05%
27.68%
23.76%
Free Cash Flow
- -
-15.61%
-371.99%
Net Income, GAAP
- -
3,776%
18,850.33%
Sales/Revenue/Turnover
- -
- -
-93.66%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
1
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Juanzi Cui
Full Time Employees
2
Sector
Healthcare
Industry
Medical - Distribution
Address
385 South Lemon Avenue Walnut CA United States of America 91789
IPO Date
Sep 11, 2014
Business
MakingORG, Inc. (CQCQ) purchases and sells Acer truncatum bunge seed oil in the People's Republic of China, outsourcing production of related health products including nervonic acid oil, coffee, and tea to third parties for distribution to end users and intermediaries in China and the United States; the company operates in the food processing and health products segment with sales concentrated in the PRC. Wholly owned subsidiaries include HK Feng Wang Group Limited and Chongqing Beauty Kenner Biotechnology Co., Ltd. Founded in 2012 and formerly known as Drimex Inc., which changed its name in August 2014, MakingORG maintains headquarters in Walnut, California, with prior references to Chongqing, China, and recent listings in City of Industry, California. The company reports minimal employees at two and focuses operations through its Chinese subsidiaries for sourcing and outsourcing. No major partnerships, acquisitions, funding rounds, or new product launches appear in recent public records for 2024-2025.